Dyslipidemia

Dyslipidemia refers to abnormal levels of lipids in the blood that gradually promote the buildup of fatty plaques within arterial walls. This process often develops silently over years, remaining undetected until it manifests as a cardiovascular event. That's what makes it so unsettling. There's no pain to warn you. No fever, no obvious sign that anything is changing inside. Most people have no idea it's happening until the day something serious occurs, For example- heart attack, stroke, moment that forces the question of how long this was going on unnoticed.

What is Dyslipidemia?

A standard fasting lipid panel measures four values: total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. Dyslipidemia is present when any one of these falls outside clinically accepted thresholds.

LDL (low-density lipoprotein) carries cholesterol to peripheral tissues and is the principal atherogenic particle. It infiltrates the arterial wall, oxidises and triggers the inflammatory cascade that builds atherosclerotic plaques. HDL does the reverse: it retrieves cholesterol from tissues and delivers it to the liver for clearance. Triglycerides are the storage form of dietary fat, and high circulating levels impair lipoprotein lipase function while independently raising cardiovascular risk.

Dyslipidemia differs from hyperlipidemia, which specifically means excess lipids. Dyslipidemia is broader, it includes low HDL, a deficiency state that carries real cardiovascular risk without any lipid being elevated.

Types of Dyslipidemia

Classification is based on which lipid fraction is abnormal:

Hypercholesterolaemia: Isolated LDL elevation. The most common type, often with a genetic component.
Hypertriglyceridaemia: Triglycerides above 150 mg/dL. Levels above 500 mg/dL significantly raise the risk of acute pancreatitis.
Mixed dyslipidaemia: Concurrent LDL and triglyceride elevation. Seen in metabolic syndrome, type 2 diabetes, and obesity.
Low HDL cholesterolaemia: Reduced HDL independent of LDL. A significant cardiovascular risk factor, particularly in women post-menopause.
Familial hypercholesterolaemia (FH): A monogenic disorder caused by LDL receptor gene mutations. Severely elevated LDL from birth, frequently underdiagnosed, and associated with premature coronary artery disease if left untreated.

Dyslipidemia Symptoms

Most patients have no symptoms at all. When physical signs do appear, they are associated with markedly elevated lipid levels:

Xanthomas: Firm yellowish deposits beneath the skin, especially over the Achilles tendon or hand extensor tendons. Highly specific for familial hypercholesterolaemia.
Xanthelasma: Flat yellowish plaques at the inner corners of the eyelids.
Arcus corneae: A grey-white ring around the corneal periphery.
Eruptive xanthomas: Small yellowish skin papules over the trunk, buttocks, or extensor surfaces, appearing when triglycerides exceed 1,000 mg/dL.
Lipaemia retinalis: Pale discolouration of retinal vessels on fundoscopy, seen in severe hypertriglyceridaemia.

What usually brings patients to clinical attention is not the dyslipidemia itself but a downstream complication like chest pain, a TIA, or an episode of abdominal pain from pancreatitis.

Dyslipidemia Causes

Causes are split into primary (genetic) and secondary (acquired), with most patients carrying both to some degree.

Primary causes include familial hypercholesterolaemia, familial combined hyperlipidaemia, familial hypertriglyceridaemia, and polygenic hypercholesterolaemia, where multiple low-effect gene variants accumulate and are amplified by diet and lifestyle.

Secondary causes are conditions and behaviours that disrupt normal lipid metabolism:

A diet high in saturated fat, trans fat, or refined carbohydrates
Type 2 diabetes and insulin resistance
Hypothyroidism - reduces LDL receptor activity, raises LDL
Chronic kidney disease and nephrotic syndrome
Visceral obesity
Medications like corticosteroids, thiazide diuretics, beta-blockers, antipsychotics, and some antiretrovirals
Excessive alcohol intake.

Risk Factors for Dyslipidemia

Many factors increase the risk of dyslipidemia. These include:

First-degree relative with dyslipidemia or premature cardiovascular disease
Age above 35 in men, above 45 in women
Type 2 diabetes or insulin resistance
Abdominal obesity
Hypothyroidism or chronic kidney disease
Sedentary lifestyle and smoking
High saturated and trans fat diet.

Complications of Dyslipidemia

The central danger is atherosclerosis, progressive plaque accumulation in arterial walls that narrows vessel lumen and raises the risk of acute thrombotic events. Other complications are:

Coronary artery disease
Ischaemic stroke and TIA
Peripheral artery disease
Acute pancreatitis
Aortic valve stenosis
Ischaemic cardiomyopathy.
Peripheral artery disease, liver cirrhosis

Diagnosis of Dyslipidemia

A fasting lipid panel, drawn after 9–12 hours of fasting, is the standard diagnostic test. It measures total cholesterol, LDL, HDL, and triglycerides. Non-HDL cholesterol (total cholesterol minus HDL) is a clinically useful additional target, particularly in patients with high triglycerides.

When secondary causes are suspected, additional tests include TSH, fasting blood glucose or HbA1c, serum creatinine, urine protein, and liver function tests.

Lipoprotein(a) is now recommended as a one-time measurement for cardiovascular risk stratification, as elevated Lp(a) carries independent risk not reflected in standard lipid values.

In intermediate-risk patients, carotid intima-media thickness measurement or coronary artery calcium scoring can sharpen risk stratification and guide treatment decisions.

Dyslipidemia Treatment

Treatment intensity is determined by the patient's cardiovascular risk category, not lipid values in isolation.

Lifestyle modifications: A diet low in saturated fat, elimination of trans fats, increased soluble fibre, and 150 minutes of moderate aerobic activity per week typically reduces LDL by a lot and modestly raises HDL.

Medications:

Statins to reduce LDL levels
Cholesterol absorption inhibitors blocks intestinal cholesterol absorption via the NPC1L1 transporter
PCSK9 inhibitors to prevent LDL receptor degradation, lowering LDL by 50–70%
Fibrates for severe hypertriglyceridaemia
Prescription omega-3 fatty acids to lower triglycerides and reduce cardiovascular events in high-risk patients.

When to See a Doctor for Dyslipidemia

Adults above 20 with no risk factors should have a fasting lipid panel every 4–6 years.

Consult a doctor if:

Adults with diabetes, hypertension, obesity, or family history of heart disease: annual screening or as advised.
Children with a first-degree relative with familial hypercholesterolaemia
Any chest pain, sudden neurological deficit, or unexplained abdominal pain
Visible xanthomas or xanthelasma.

Prevention of Dyslipidemia

You can manage your lipid profile by adopting a healthy lifestyle. These include:

Replace saturated and trans fats with unsaturated fats from olive oil, nuts, and fatty fish.
Increase soluble fibre through oats, legumes, psyllium, and vegetables.
Maintain 150 minutes of moderate aerobic activity weekly; include resistance training.
Achieve and sustain a healthy body weight even a 5–10% weight loss improves the full lipid panel.
Stop smoking. HDL begins to improve within weeks of cessation.
Limit alcohol. Triglycerides are particularly sensitive to intake.
Screen regularly.

Conclusion

Dyslipidemia is silent, common, and consequential. It does not produce symptoms that drive patients to a clinic, which is precisely why screening matters. The lipid abnormalities it causes are measurable from a single blood draw, modifiable through diet and medication, and directly linked to heart attack and stroke risk. Early identification and consistent management are the variables that change outcomes.

If you have not had a lipid panel in the past few years, or if previous results were abnormal without follow-up, speak to a specialist. The window for prevention is long and the intervention required is often simple.

FAQs

1. Is dyslipidemia curable?

Secondary dyslipidemia due to hypothyroidism, medication effects, or a poor diet can often be resolved by treating the underlying cause. Genetic forms are lifelong conditions managed with pharmacotherapy, but lipid levels can be brought to target and cardiovascular risk substantially reduced with consistent treatment.

2. Who is at risk for dyslipidemia?

Those with a family history of high cholesterol or premature heart disease face the highest genetic risk. Individuals in night shift with type 2 diabetes, obesity, hypothyroidism, chronic kidney disease, or those who smoke, drink excessively, or eat a high saturated fat diet, alcohol intake, sedentary life style, fast food and junk food are also at elevated risk.

3. Is dyslipidemia the same as high cholesterol?

Not exactly. High cholesterol refers specifically to elevated LDL or total cholesterol. Dyslipidemia is a broader term; it includes elevated triglycerides, reduced HDL, or any combination, regardless of whether total cholesterol is high.

4. What foods should I avoid with dyslipidemia?

Avoid saturated fats from red meat, butter, full-fat dairy, palm oil, and coconut oil. Eliminate trans fats in processed baked goods and margarine. Cut refined carbohydrates and added sugar, which are the main dietary drivers of elevated triglycerides.

5. Is dyslipidemia a kidney disease?

No. Dyslipidemia is a lipid disorder. However, chronic kidney disease commonly causes dyslipidemia by impairing lipoprotein metabolism, reducing HDL and raising triglycerides and LDL. The two conditions frequently co-exist and compound each other's cardiovascular consequences.

6. Can dyslipidemia be hereditary?

Yes. Familial hypercholesterolaemia is an autosomal dominant condition caused by LDL receptor gene mutations, producing severely elevated LDL from birth. Familial combined hyperlipidaemia and polygenic forms also carry strong genetic components and run in families.

7. How does diet affect dyslipidemia?

Saturated and trans fats reduce LDL receptor expression, raising circulating LDL. High refined carbohydrate intake drives hepatic triglyceride synthesis. Soluble fibre binds bile acids in the gut, reducing cholesterol recycling and lowering LDL. Omega-3 fatty acids from oily fish lower triglycerides directly. Diet is one of the most modifiable variables in lipid management.

8. Is dyslipidemia reversible?

Secondary dyslipidemia with an identifiable trigger is often substantially reversible. Genetic dyslipidemia is not reversible in the strict sense, but with pharmacotherapy, lipid levels can be normalised and cardiovascular risk reduced.

9. What foods are good for dyslipidemia?

Fatty fish (salmon, mackerel, sardines), oats, barley, legumes, nuts, olive oil, fruits, and vegetables all benefit the lipid profile. Plant sterols in fortified foods competitively inhibit cholesterol absorption and offer a modest additional LDL reduction.

10. Can dyslipidemia lead to a heart attack?

Yes. Elevated LDL is among the strongest modifiable risk factors for myocardial infarction. LDL particles infiltrate arterial walls, triggering atherosclerotic plaque growth. When a plaque ruptures, the resulting clot can occlude the coronary artery acutely. The risk rises with the duration and severity of LDL elevation, underscoring the importance of early treatment.

11. How often should cholesterol be checked?

Every 4-6 years for low-risk adults from age 20 onwards. Annually for those with diabetes, hypertension, obesity, or a positive family history. Patients on lipid-lowering therapy should be retested 6-12 weeks after starting or changing treatment, then every 3-12 months once targets are stable.